Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial.
Wainwright CE, Vidmar S, Anderson V, Bourgeat P, Byrnes C, Carlin JB, Cheney J, Cooper P, Davidson A, Gailer N, Grayson-Collins J, Quittner A, Robertson C, Salvado O, Zannino D, Armstrong FD; ACFBAL; CF-GAIN Study Groups. Wainwright CE, et al. Among authors: gailer n. Lancet Respir Med. 2024 Sep;12(9):703-713. doi: 10.1016/S2213-2600(24)00170-X. Epub 2024 Jun 5. Lancet Respir Med. 2024. PMID: 38851197 Clinical Trial.
Factors in childhood associated with lung function decline to adolescence in cystic fibrosis.
Begum N, Byrnes CA, Cheney J, Cooper PJ, Fantino E, Gailer N, Grimwood K, GutierrezCardenas D, Massie J, Robertson CF, Sly PD, Tiddens HA, Wainwright CE, Ware RS. Begum N, et al. Among authors: gailer n. J Cyst Fibros. 2022 Nov;21(6):977-983. doi: 10.1016/j.jcf.2022.03.008. Epub 2022 Mar 24. J Cyst Fibros. 2022. PMID: 35341694 Free article.
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort.
Wijker NE, Vidmar S, Grimwood K, Sly PD, Byrnes CA, Carlin JB, Cooper PJ, Robertson CF, Massie RJ, Kemner van de Corput MPC, Cheney J, Tiddens HAWM, Wainwright CE; Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) and Follow-up of the ACFBAL (CF-FAB) study groups; following investigators constitute the ACFBAL Study Investigators Group:; following investigators constitute the CF FAB Study Investigators Group:; Additional contributions: We are indebted to all current and former clinical and research staff from Queensland Children's Hospital, Brisbane:. Wijker NE, et al. Eur Respir J. 2020 Apr 3;55(4):1901694. doi: 10.1183/13993003.01694-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 31949117 Free article.
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.